[The effect of perioperative ERAS pathway management on short-and long-term outcomes of gastric cancer patients].
Fangzheng Yang, Hao Wang, Dongsheng Wang, Zhaojian Niu, Shikuan Li, Jian Zhang, Liang Lü, Dong Chen, Yu Li, Haitao Jiang, Hongding Han, Haichen Chu, Shougen Cao, Yanbing Zhou
Abstract
Perioperative ERAS pathway management is safe and feasible for patients with gastric cancer, without increasing the incidence of complications and 30-day readmission rate. This protocol can improve the prognosis of patients with gastric cancer.
Topics & Concepts
MedicinePerioperativePropensity score matchingSurgeryLymphadenectomyAtelectasisIncidence (geometry)Retrospective cohort studyCancerGastrectomyBlood lossInternal medicineLungOpticsPhysicsEnhanced Recovery After SurgeryGastric Cancer Management and OutcomesClinical practice guidelines implementation